Thus, future studies are required for exploring the molecular mechanisms by which p21 regulates the tumor suppressive function for miR-31 and potential interventions to disrupt the p21-mediated suppression of miR-31 for treatment of ESCC patients. Here, CDKN1A is linked to neoplasm.